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The current study examined the utility of the recently released Minnesota Multiphasic Personality
Inventory—2 Restructured Form (MMPI–2-RF; Ben-Porath & Tellegen, 2008) validity scales to detect
feigned psychopathology in a criminal forensic setting. We used a known-groups design with the
Structured Interview of Reported Symptoms (SIRS; Rogers, Bagby, & Dickens, 1992) as the external
criterion to determine groups of probable malingering versus nonmalingering. A final sample of 125
criminal defendants, who were administered both the SIRS and the MMPI–2-RF during their evaluations,
was examined. The results indicated that the two MMPI–2-RF validity scales specifically designed to
detect overreported psychopathology, F-r and FP-r, best differentiated between the malingering and
nonmalingering groups. These scales added incremental predictive utility to one another in this differ-
entiation. Classification accuracy statistics substantiated the recommended cut scores in the MMPI–2-RF
manual (Ben-Porath & Tellegen, 2008) in this forensic setting. Implications for these results in terms of
forensic assessment and detection of malingering are discussed.
Keywords: MMPI–2-RF, validity scales, malingering, forensic assessment
It is vital that psychologists have instruments at their disposal
that can effectively determine the veracity of symptom presenta-
tion in forensic psychological evaluations given the high stakes
associated with such proceedings. It is not uncommon for criminal
defendants to feign psychopathology (particularly psychosis) dur-
ing the course of competency and criminal responsibility evalua-
tions to avoid or delay punishment (Rogers, 2008). To date, the
Minnesota Multiphasic Personality Inventory—2 (MMPI–2;
Butcher et al., 2001) is one of the most widely used instruments of
any general assessment measure (i.e., personality assessment, in-
telligence assessment, neuropsychological assessment, etc.) used
by clinical psychologists across various clinical and forensic
settings (Archer, Buffington-Vollum, Stredny, & Handel, 2006;
Camara, Nathan, & Puente, 2000; Lally, 2003). The instrument
has also been touted by neuropsychologists as one of the top five
most widely used instruments in the determination of response bias
(Sharland & Gfeller, 2007). Additionally, numerous meta-analyses
(e.g., Berry, Baer, & Harris, 1991; Rogers, Sewell, Martin, &
Vitacco, 2003; Rogers, Sewell, & Salekin, 1994) have found the
MMPI–2 Infrequency scales effective in identifying overreported
psychopathology.
Most of the studies included in the aforementioned meta-
analyses, however, have involved analogue simulation designs.
These research designs typically involve the administration of the
MMPI–2 to psychologically well-adjusted college students under
the instruction to feign symptoms of mental illness and comparing
them to psychiatric patients (e.g., Graham, Watts, & Timbrook,
1991). Though simulation studies provide important experimental
control, they are often limited with regard to external validity,
making it difficult to determine the degree to which the results
generalize to actual forensic evaluations. Rogers et al. (1994) and
Rogers and Bender (2003) specifically noted that the majority of
the malingering research involving the MMPI–2 has been void of
actual malingerers.
Although they represent the standard in cognitive malingering
research, studies utilizing a known-groups design (i.e., defining
symptom-overreporting groups based on an empirically validated
response bias criterion) are scarce with regard to feigned psycho-
pathology and are sometimes confounded by methodological con-
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cerns. For example, Gassen, Pietz, Spray, and Denney (2007)
found Megargee’s (2004) Criminal Offender Infrequency (Fc)
scale produced the highest hit rate of any MMPI–2 validity scale
in detecting criminal defendants who were classified as malinger-
ing by the Structured Interview of Reported Symptoms (SIRS;
Rogers, Bagby, & Dickens, 1992). However, it is difficult to
determine how to interpret these results, as defendants were only
administered the SIRS if the evaluating clinician determined that
their MMPI–2 results were indicative of symptom feigning. Lewis,
Simcox, and Berry (2002) also investigated a sample of criminal
defendants using the SIRS as the criterion for defining malinger-
ing. However, the authors noted that, to increase the number of
feigning participants for comparison, a portion of the selected
sample was only administered the MMPI–2 and SIRS “because of
clinical suspicion of feigning” (Lewis et al., 2002, p. 172). Utiliz-
ing the procedures in the two aforementioned studies makes sense
in clinical practice; however, such practice raises the possibility of
criterion contamination and could therefore confound accurate
prediction models.
Furthermore, studies that investigate the utility of the MMPI–2
validity scales in forensic populations are also rare (Bagby, Rog-
ers, & Buis, 1994; Iverson, Franzen, & Hammond, 1995; Lewis et
al., 2002; Wygant et al., 2007). For instance, Wygant et al. (2007)
examined the relationship between MMPI–2 validity scales and
cognitive symptoms validity measures across civil and criminal
forensic settings and found that Infrequency (F) and Infrequency-
Psychopathology (FP) were related to cognitive response bias in
addition to overreported psychopathology in criminal forensic
evaluations. Utilizing exploratory factor analysis, Nelson, Sweet,
Berry, Bryant, and Granacher (2007) suggested that F and FP load
on a factor representative of overreporting psychotic/rarely en-
dorsed symptoms among compensation seeking plaintiffs.
Recently, two studies employing known-groups designs (Boccac-
cini, Murrie, & Duncan, 2006; Toomey, Kucharski & Duncan, 2009)
examined archival samples of criminal defendants derived from the
same setting who had been administered both the MMPI–2 and SIRS
as part of a forensic evaluation. These studies found that the F
(Boccaccini et al., 2006; Toomey et al., 2009) and the FP (Toomey et
al., 2009) scales performed quite well in differentiating between a
SIRS-defined malingering group and a nonmalingering group.
To summarize, in a review of the extensive literature of the F
and FP scales in detecting malingering in both simulation and
known-groups designs, Berry and Schipper (2007) noted that while
considerable consistency is evident among mean cutting scores,
sensitivity, specificity, and effect sizes (Cohen’s ds) across the two
designs, there appears to be a large decline in mean cut scores for
F and mean sensitivity for FP when moving from simulation to
known-groups designs. However, the authors nonetheless noted
that, overall, in psychiatric and criminal neuropsychological eval-
uations, the use of F and FP to assess feigning and exaggeration
appear well supported (Berry & Schipper, 2007). No study to date,
however, has examined the MMPI—2 Restructured Form (MMPI–
2-RF; Ben-Porath & Tellegen, 2008) validity scales using a
known-groups design in a criminal forensic setting.
The MMPI—2 Restructured Form
The MMPI–2-RF is a substantially shortened version of the test
designed to represent the clinically significant substance of the
MMPI–2 item pool with a comprehensive set of psychometrically
efficient measures. It is linked conceptually and empirically to
modern theories and models of psychopathology and personality.
The test includes six sets of scales: Validity, Higher-Order, Re-
structured Clinical (RC), Specific Problem, Interest, and Person-
ality Psychopathology Five scales.
The current investigation focused on the validity of the MMPI–
2-RF scales designed to measure symptom overreporting. These
indicators include revised versions of three current MMPI–2 scales
and a new measure introduced with the MMPI–2-RF. The Infre-
quent Responses (F-r) scale serves as a general overreporting
indicator and comprises 32 items that are rarely endorsed by the
test’s normative sample (i.e., were answered in the keyed direction
by 10% or less of both men and women in the sample).
The Infrequent Psychopathology Responses (FP-r) scale is an
indicator of overreported symptoms of severe psychopathology.
The MMPI–2 FP scale, composed of 27 items, was developed
originally by Arbisi and Ben-Porath (1995) to complement the F
scale, on which scores are confounded by genuine reports of severe
psychopathology. FP-r is shorter than its MMPI–2 counterpart,
consisting of 21 items, 17 of which also are scored on FP. Item
reduction involved the removal of those items also scored on the
MMPI–2 Lie scale, those included on the new Infrequent Somatic
Responses (FS) scale, and several with wording judged to be
ambiguous. Four items were also added to FP-r based on multiple
regression analyses that indicated that they could contribute incre-
mentally to the scale in the detection of overreported test protocols
(Tellegen & Ben-Porath, 2008).
The FS scale was added to the MMPI–2-RF to measure overre-
ported somatic complaints using the traditional infrequency ap-
proach. Wygant, Ben-Porath, and Arbisi (2004) developed FS by
identifying 16 items with somatic content that were endorsed by
less than 25% of patients in two large archival medical samples
and an archival chronic pain sample, comprising over 55,000
patients. Wygant (2007) examined the scale in several simulation,
known-groups, and mental health samples and found that it was
significantly elevated among patients who failed cognitive symp-
tom validity tests and participants instructed to feign symptoms
consistent with a head injury. FS was also less correlated with
measures of genuine somatic complaints and mood psychopathol-
ogy than other MMPI–2 validity scales, and the scale added
incrementally to other MMPI–2 validity scales in predicting var-
ious response bias criteria.
Finally, a revised version of the Symptom Validity (FBS-r) scale
assesses noncredible somatic and neurocognitive complaints. Re-
search has found that the original Symptom Validity scale (Lees-
Haley, English, & Glenn, 1991),1 which was developed specifi-
cally as a validity scale for use in civil forensic assessments, is
sensitive to noncredible somatic responding (e.g., Bianchini,
Etherton, Greve, Heinly, & Meyers, 2008; Larrabee, 1998, 2003),
suboptimal effort on cognitive symptom validity tests (e.g., Grei-
ffenstein, Baker, Gola, Donders, & Miller, 2002; Larrabee, 2003;
Ross, Millis, Krukowski, Putnam, & Adams, 2004; Wygant et al.,
1 The Symptom Validity Scale (FBS) was formerly labeled the Fake Bad
Scale but was renamed when officially adopted on the MMPI–2 scoring
materials to better reflect its construct validity and to avoid the negative
connotation associated with such a label.
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2007), and malingered neurocognitive dysfunction (Greve, Bi-
anchini, Love, Brennan, & Heinly, 2006). The FBS-r comprises 30
of the original 43 FBS items. Whereas the three infrequency
scales, F-r, FP-r, and FS, do not overlap in content, FBS-r shares
three items with FS and one with FP-r.
Ben-Porath and Tellegen (2008) reported correlations between
the MMPI–2-RF and MMPI–2 versions of F-r, FP-r, and FBS-r
showing strong covariation in scores on the original and revised
scales (correlation coefficients greater than .90). However, they
noted the need to examine the utility and efficacy of various
cutoffs on the revised scales in detecting noncredible symptom
reporting. To date, only one published study has examined the
validity and clinical utility of the MMPI–2-RF validity scales
designed to detect overreporting. Wygant et al. (2009) examined
the these scales in two simulation samples and one known-groups
sample that utilized cognitive symptom validity tests as a criterion
and found that the scales were able to detect the various threats to
protocol validity in civil forensic settings.
The Current Study
The current investigation was designed to examine the validity
and clinical utility of the MMPI–2-RF validity scales in detecting
malingered psychopathology in a known-groups design. We used
the SIRS (Rogers et al., 1992), a well-validated measure of ma-
lingering often considered a gold standard, as the external crite-
rion. Because the SIRS primarily reflects malingering of extreme
psychopathology, we expected that the F-r and FP-r scales would
exhibit greater utility in differentiating between the malingering
and nonmalingering groups than would FS and FBS-r, which are
specifically focused on detecting noncredible somatic and neuro-
cognitive responding. Because of their nonoverlapping nature,
somewhat differing detection strategies (rare symptoms [FP-r] vs.
quasi-rare symptoms [F-r]; see Rogers, 2008), and the fact that F-r
is more saturated with emotional content whereas FP-r is more
associated with bizarre content (Tellegen & Ben-Porath, 2008), we
expected that these scales would add incremental predictive utility
to one another in detecting malingering. Finally, we also examined
the optimal cut scores for these scales in detecting malingered
psychopathology and compared them to those proposed in the
MMPI–2-RF manual (Ben-Porath & Tellegen, 2008).
Method
Participants
Potential participants consisted of 155 men who were selected
from an archival database of criminal defendants referred by the
federal courts for competency to stand trial, criminal responsibil-
ity, or aid-in-sentencing evaluations between 1994 and 2004.2 A
large portion of these data has been used previously in the exam-
ination of MMPI–2 validity scales (Toomey et al., 2009). Each of
these individuals had been administered the MMPI–2 and the SIRS
(Rogers et al., 1992) as part of their psychological evaluation.
Individuals who produced an excessive amount of unscorable
responding (i.e., Cannot Say  17), inconsistent (i.e., Variable
Response Inconsistency [VRIN-r]  79T), or indiscriminant fixed
(i.e., True Response Inconsistency [TRIN-r]  79T) responding
based on MMPI–2-RF scales were excluded from the study. These
criteria led to the exclusion of 30 (or 19.4%) individuals.
The final sample consisted of 125 men with a mean age of 36.7
years (SD  10.2). They had an average education of 10.2 years
(SD  2.9). In terms of race/ethnicity, participants were Caucasian
(51.8%), African American (44.0%), or Hispanic (3.5%), with the
remaining participants of other or mixed ethnicities. Almost 64%
of the sample reported prior mental health treatment, while 38%
reported a history of at least one prior psychiatric hospitalization
(M  2.7, SD  7.2). Approximately 84% of participants reported
substance abuse problems, and 94% had at least one prior felony
conviction. There were no statistically significant differences be-
tween those participants included versus excluded based on
MMPI–2-RF criteria on any of these descriptive variables.
Measures
MMPI–2-RF. The MMPI–2-RF (Ben-Porath & Tellegen,
2008) is a 338-item self-report inventory on which participants
respond “true” or “false” to a variety of statements indicating
personality and psychopathology. The entire MMPI–2-RF item
pool can be derived from the original MMPI–2 (administered in
this sample), and the same normative sample is used with a few
modifications (Ben-Porath & Tellegen, 2008). The MMPI–2-RF
technical manual provides extensive reliability and validity data
for this instrument (Tellegen & Ben-Porath, 2008). In addition,
Tellegen and Ben-Porath (2008) presented data indicating that the
MMPI–2-RF scale scores derived from administration of the 567-
item MMPI–2 booklet are interchangeable with results obtained
from administration of the 338-item MMPI–2-RF booklet, which
included virtually identical mean scale elevations and correlations
with external criteria. For this study, we used the F-r, FP-r, FS, and
FBS-r validity scales. See the earlier description of their develop-
ment and initial validation. We also used the RC scales for the
differential symptoms presentation analyses described later.
SIRS. The SIRS (Rogers et al., 1992) was used as the external
criterion from which malingering and nonmalingering groups were
derived. It is a 172-item structured interview designed to assess
malingering and overreported response styles. It contains eight
primary scales that are designed for specific detection strategies.
These include Rare Symptoms, Improbable and Absurd Symp-
toms, Symptom Combinations, Blatant Symptoms, Subtle Symp-
toms, Symptom Severity, Symptom Selectivity, and Reported Ver-
sus Observed Symptoms scales. Four classifications can be derived
from each scale: honest, indeterminate, probable faking, and def-
inite faking. Several reviews (e.g., Rogers, 2001) have indicated
excellent psychometric properties for the SIRS, and it has been
frequently used as an external criterion measure in known-groups
designs for other structured interviews (e.g., Vitacco, Rogers,
Gabel, & Munizza, 2007) and self-report inventories (e.g., Edens,
Poythress, & Watkins-Clay, 2007) designed to detect malingering.
Because we used an archival database in which we did not have
2 Previous research from this archival database has indicated that about
83% of all individuals evaluated were administered the SIRS. There was no
discernible pattern as to why this instrument was administered versus not
administered. There were no significant differences between those admin-
istered versus not administered the SIRS on any demographic or mental
health variables (see e.g., Boccaccini et al., 2006; Toomey et al., 2009).
24 SELLBOM, TOOMEY, WYGANT, KUCHARSKI, AND DUNCAN
access to individual SIRS items, we were unable to calculate
reliability estimates for the current sample. However, numerous
previous studies have shown acceptable to excellent internal con-
sistencies (range: .77–.96) and excellent interrater reliability
(range: .97–1.00) for SIRS scales (e.g., Rogers et al., 1992; Ustad,
1998; Vitacco et al., 2007).
Procedures
We employed a known-groups design (see Rogers, 2008) to
examine the utility of the MMPI–2-RF validity scales in detecting
malingering. The SIRS was used as an external criterion to deter-
mine group membership (i.e., malingering or nonmalingering). We
used a strict cutoff of three or more subscales in the probable range
or one score in the definite range to determine malingering, as this
cutoff off has been well validated in forensic populations (e.g.,
Rogers, Hinds, & Sewell, 1996). This resulted in 27 participants
(or 21.6%) being classified as malingering. The remaining 98
participants were classified as nonmalingering.3 Moreover, the
SIRS manual classifies individuals who score in the probable
range on one or two subscales as indeterminate. Eight (or 6.4%)
participants in the present sample would fall in this category.
Because this group would be too small to be analyzed separately
but their presence in the nonmalingering group might violate the
assumption of a bona fide known-groups design, we also compared
the malingering group to a nonmalingering group (n  90) from
which these 8 indeterminate participants were excluded.
The participants represented an archival sample of convenience
and were not randomly selected. Each participant had undergone a
psychological evaluation for the federal court. All treatment and
psychiatric hospitalization information was gathered through pre-
trial service reports, prior hospitalization records, and clinical
interviews. All psychological testing was conducted by the foren-
sic evaluator taking the ability and cooperation of the defendant
into consideration. Those who were not fluent in English, refused
specific psychological tests, or produced protocols suggestive of
inconsistent responding were excluded as stated earlier. The use of
human participants for this study was approved by the Federal
Bureau of Prisons and university institutional review boards.
Results
For all analyses, we used untruncated T scores for MMPI–2-RF
scales. Tellegen and Ben-Porath (2008) recommend the use of
these scores as artificially truncating validity scale scores (20T at
the lower end and 120T at the higher end) and substantive scale
scores (20T at the lower end and 100T at the higher end) artifi-
cially restricts the range of these variables and, thus, attenuates
variance.
Differential Symptom Presentation
Figure 1 shows the mean profiles for the research conditions
(i.e., malingering vs. two nonmalingering groups) on the MMPI–
2-RF RC scales. We conducted this analysis with the expectation
that malingering participants actually exaggerate their symptom
presentation relative to the nonmalingering participants. A
Bonferroni-corrected alpha set at p  .006 (i.e., .05/9 compari-
sons) was applied for each individual comparison. Overall multi-
variate analysis of variance (MANOVA) models were significant,
Hotelling’s T  1.068, F(9, 115)  13.65, p  .001, 2  0.52,
for the malingering versus nonmalingering group (including inde-
terminates), and Hotelling’s T  1.426, F(9, 107)  16.95, p 
.001, 2  0.59, for the malingering versus nonmalingering group
(excluding indeterminates). The malingering group had signifi-
cantly higher scores on all of the RC scales (except RC3 [Cyni-
cism] and RC9 [Hypomanic Activation]) relative to both nonma-
lingering groups, all Fs(1, 123)  18.72, all ps  .001, all 2s 
0.13 (vs. nonmalingering group including indeterminates), and all
Fs(1, 115)  19.97, all ps  .001, all 2s  0.15 (vs. nonmalin-
gering group excluding indeterminates).
Validity Scale Group Differences
We next conducted a one-way MANOVA to determine whether
there were overall differences on the MMPI–2-RF overreporting
validity scales across the two conditions. The overall models were
statistically significant—Hotelling’s T  .983, F(4, 120)  29.49,
p  .001, 2  .50 (malingering vs. nonmalingering with inter-
mediates), and Hotelling’s T  1.356, F(4, 112)  37.98, p 
.001, 2  .58 (malingering vs. nonmalingering without interme-
diates). We followed up with univariate analyses of variance and
Tukey’s honestly significant difference post hoc tests for each
individual validity scale (i.e., F-r, FP-r, FS, and FBS-r) to test for
differences between the malingering and nonmalingering groups.
These results are displayed in Table 1. All four validity scale
scores in the malingering condition were significantly higher com-
pared to those of the nonmalingering condition. F-r and FP-r had
the largest effect sizes, as expected, given that these scales were
designed to detect overreported psychopathology. FBS-r had a
larger effect size relative to FS, which is not surprising given the
3 We realize that no individual method of detecting malingering is
perfect; as such, these groups would be best referred to as probable
malingering and probable nonmalingering. However, for simplicity of
writing, we do not use probable when referring to these conditions.
Figure 1. Mean Minnesota Multiphasic Personality Inventory—2 Re-
structured Form Restructured Clinical (RC) scale profiles for malingering
and two nonmalingering groups. RCd  Demoralization; RC1  Somatic
Complaints; RC2  Low Positive Emotions; RC3  Cynicism; RC4 
Antisocial Behavior; RC6  Ideas of Persecution; RC7  Dysfunctional
Negative Emotions; RC8  Aberrant Experiences; RC9  Hypomanic
Activation.
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broader nature of the overreported symptoms captured by the
FBS-r scale. The pattern of results was identical, albeit with
slightly larger effect sizes, when intermediate malingering partic-
ipants were removed from the nonmalingering group.
Incremental Validity
We next conducted hierarchical logistic regression analyses to
determine whether other scales added to F-r or FP-r in differenti-
ating between malingering and nonmalingering conditions. We
chose these two scales because they were developed to detect
overreporting of psychopathology and are associated with the
largest effect sizes in this sample. We conducted six separate
planned regression analyses. First, we examined whether any of
the scales would add incremental predictive utility to F-r. In three
regressions, F-r was entered in the first step, and FP-r, FS, or FBS-r
was entered in the second step. Next, three additional analyses
were conducted in which FP-r was entered in the first step and the
remaining three scales in respective second steps. These analyses
were repeated when intermediate malingering participants were
removed from the nonmalingering groups. Table 2 shows the
results of these analyses, which indicate that only FP-r added
incrementally to F-r in differentiating the malingering and nonma-
lingering conditions. In the analyses where FP-r was entered first,
both F-r and FBS-r added significant incremental utility to FP-r.
This pattern was identical when intermediate malingerers were
removed.
Classification Accuracy
Classification accuracies of the F-r and FP-r validity scales in
differentiating the two overreporting groups from the patient group
were examined using receiver operating characteristic (ROC)
curves, which are calculated based on a function of sensitivity and
1  specificity.4 Overall predictive performance was assessed
using the area under the ROC curve (AUC). In addition, positive
and negative predictive powers (PPP and NPP) are indices of
diagnostic efficiency in that they provide a probability that the
individual is (or is not) engaging in invalid responding given a
certain cutoff value. Although predictive powers are more directly
meaningful to clinicians (because they only have access to a test
score) and therefore emphasized here, they are heavily influenced
by base rates. We therefore provide estimates of predictive
powers across three different base rates, (a) base rate of .15,
because it represents the lower end of empirically identified
overreporting rates (Rogers, Salekin, Sewell, Goldstein, & Leo-
nard, 1998; Rogers et al., 1994); (b) base rate of .30, which
represents the higher end of empirically derived overreporting
rates (e.g., Mittenberg, Patton, Canyock, & Condit, 2002); and
(c) base rate of .50, which yields the fewest classification errors
(i.e., sensitivity and specificity are maximized), but also because
Ardolf, Denney, and Houston (2007) found that negative response
bias could occur in over 50% in individuals referred for consecu-
tive criminal evaluations.
We selected a range of possible optimal cutoff scores with an
emphasis on reducing false-positive predictions. In most clinical
situations, there is an emphasis on minimizing false-positive pre-
diction errors (i.e., 1  PPP), as clinicians prefer to avoid desig-
nating test takers as malingerers unless substantial evidence for
such responding is present. This is favorable to avoiding false-
negative predictions, as such errors have less potential negative
impact on the individual. Bagby et al. (1994) recommended that
PPP values should never be lower than .80 (i.e., false-positive
prediction error rate of 20%); however, in high-stakes settings such
as these, we would argue for even greater PPP values of .90 or
higher (cf. Rogers, 2008).
For ROC analyses with F-r, the AUC was .91 (SE  .029) for
differentiating the malingering and nonmalingering conditions.
The AUC increased to .93 (SE  .027) when intermediate partic-
ipants were excluded. The ROC curve of F-r (and relative to FP-r)
can be seen in Figures 2A and 2B. The upper half of Table 3
displays the classification accuracy statistics, with statistics to the
right of each slash mark indicating values after intermediate par-
ticipants were removed. As seen in Table 3, sensitivity for F-r is
4 Sensitivity refers to the proportion of malingering participants cor-
rectly classified at a particular cut score, whereas specificity refers to the
proportion of nonmalingering participants correctly classified below a
particular cut score.
Table 1
Means, Standard Deviations, F Tests, and Cohen’s d Effect Size Estimates for Group Differences
Scale
Malingering group
(n  25)
Nonmalingering groups
F test Effect size
With intermediates
(n  98)
Without
intermediates
(n  90)
M SD M SD M SD F1 F2 d1 d2
F-r 141.92 23.42 82.00 29.54 79.10 27.37 94.57 116.55 2.11 2.37
FP-r 122.38 35.54 68.94 22.44 66.37 19.32 91.04
 113.41 2.07 2.34
FS 98.94 25.87 69.17 24.80 67.06 24.02 29.95
 35.29 1.19 1.30
FBS-r 86.47 14.03 60.97 16.49 59.47 15.88 53.63 62.98 1.59 1.74
Note. F-r  Infrequent Responses; FP-r  Infrequent Psychopathology Responses; FS  Infrequent Somatic Complaints; FBS-r  Symptom Validity;
F1  F test between malingering group and nonmalingering group including intermediates; F2  F test between malingering group and nonmalingering
group excluding intermediates; d1  effect size for difference between malingering group and nonmalingering group including intermediates; d2  effect
size for difference between malingering group and nonmalingering group excluding intermediates.
 p  .001.
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particularly good, in that it ranges from .89 (at 120T) to .96 (100T),
and corresponding NPPs are even higher, indicating that most
malingering participants will be identified at these scores. How-
ever, as stated earlier, the most important statistic here are PPP
values, which, for F–r, do not become acceptable until the base rate
reaches .50, with a cut score of 120T providing the best balance of
predictive powers. The MMPI–2-RF manual (Ben-Porath & Tel-
legen, 2008) recommends that overreporting be suspected at F-r 
100T, which is supported by the present results in that sensitivity
and NPP (across base rates) rates are very high, but so are false-
positive predictive error rates as well—an indication that a signif-
icant proportion of nonmalingerers score high on F-r.
For ROC analyses with FP-r, the AUC was .89 (SE  .037; and
.91, SE  .035, when intermediates were excluded) for differen-
tiating the malingering and nonmalingering conditions. Figures 2A
and 2B display the ROC curve for FP-r relative to F-r. The lower
half of Table 3 displays the classification accuracy statistics. As
seen in this table, sensitivity and NPP values are lower for FP-r
compared to F-r, indicating that this scale is less sensitive in
correctly identifying malingerers. However, with our stated em-
phasis on avoiding false-positive prediction errors, the results
indicate that a cut score of 110T provides for the best PPP values
(and better relative to F-r), but these do not become acceptable
until higher base rates. Moreover, when more clean known groups
are differentiated (i.e., intermediate participants removed), PPP
values for FP-r are substantially better, especially at low base rates.
Furthermore, the MMPI–2-RF manual recommends that individu-
als who produce 80T or greater on FP-r be considered as possibly
overreporting (Ben-Porath & Tellegen, 2008). The present results
support this recommendation, as such cut scores are associated
with high sensitivity and NPP values, but in light of 78% speci-
ficity (and even lower PPP values), it will also yield many false-
positive prediction errors (up to 60%) in settings where the base
rate for overreporting is low.
Discussion
The goal of this investigation was to determine the utility of the
MMPI–2-RF validity scales in detecting malingering in a known-
groups design. We found that, as expected, F-r and FP-r were the
best scales in differentiating malingering and nonmalingering
groups as determined by the SIRS. This differentiation was also
associated with very large effect sizes, even by malingering re-
search standards (d  1.75; see Rogers, 2008). Moreover, the
effect sizes derived from the current study are quite similar to
those reported in Rogers et al.’s (2003) meta-analysis of the
MMPI–2 validity scales (i.e., mean ds  2.21 and 1.90 for F and
FP, respectively), which suggests that F-r and FP-r are as effective
in differentiating between malingered and nonmalingered profiles
as their MMPI–2 counterparts.
The other two MMPI–2-RF validity scales designed to assess
overreported response bias, FS and FBS-r, performed less well.
This finding was entirely expected, however, as F-r and FP-r are
designed to measure malingering of psychopathology, whereas FS
Table 2
Hierarchical Logistic Regression Analysis Results for Predicting Malingering Status
Step
Parameters
Model fit 2(df) w 2 change (df) w change R2 R2
Malingering group vs. nonmalingering group with intermediates
F-r entered first
1. F-r 62.11 .70 .60
2a. FP-r 65.78
 .73 3.67 .17 .63 .03
2b. FS 62.47
 .71 0.36 .05 .60 .00
2c. FBS-r 62.67 .71 0.56 .07 .61 .01
FP-r entered first
1. FP-r 52.08
 .65 .53
2a. F-r 65.78 .73 13.70 .33 .63 .10
2b. FS 53.48
 .65 1.40 .11 .54 .01
2c. FBS-r 59.31 .69 7.24 .24 .58 .04
Malingering group vs. nonmalingering group without intermediates
F-r entered first
1. F-r 69.50 .77 .68
2a. FP-r 75.44
 .80 5.94 .23 .72 .04
2b. FS 69.91
 .77 0.42 .06 .68 .00
2c. FBS-r 69.57 .77 0.07 .02 .68 .00
FP-r entered first
1. FP-r 59.67
 .71 .61
2a. F-r 75.44 .80 15.77 .37 .72 .11
2b. FS 61.79
 .73 2.12 .13 .62 .01
2c. FBS-r 67.76 .76 8.10 .26 .66 .05
Note. Nagelkerke R2 estimation was used for logistic regression. F-r  Infrequent Responses; FP-r 
Infrequent Psychopathology Responses; FS  Infrequent Somatic Complaints; FBS-r  Symptom Validity; w 
effect size for 2 statistic; w change  effect size for 2 change statistic.
 p  .05.  p  .01.  p  .001.
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and FBS-r are more specifically focused on the detection of
noncredible somatic and/or neurocognitive complaints (see Wyg-
ant et al., 2009). Nonetheless, FS and FBS-r were still associated
with respectable effect sizes in differentiating the malingering and
nonmalingering groups, suggesting some utility in this setting.
This finding is also consistent with the previous observation that
individuals in criminal forensic contexts tend to malinger symp-
toms across all three domains of response bias (i.e., psychopathol-
ogy, cognitive, somatic), whereas individuals in civil forensic
settings tend to be more specific in their symptom presentation
(Wygant et al., 2007).
The current findings also indicate that F-r and FP-r complement
each other in detecting malingering. The regression analyses indi-
cate that both add incremental predictive utility to one another,
showing that both scales add something unique in differentiating
between malingering and nonmalingering individuals. One poten-
tial reason for this finding is that F-r and FP-r reflect different
response bias detecting strategies (Rogers, 2008). FP-r adheres to
the more stringent rare symptoms strategy, which focuses on
identifying symptoms that are rarely reported among genuine
patients with mental illness (Rogers, 2008). F-r, on the other hand,
corresponds best to the quasi-rare symptoms strategy, which fo-
cuses on identifying symptoms that are rare in a normal popula-
tion, and it is quasi because individuals with actual psychopathol-
ogy could endorse these items as well (Rogers, 2008). Thus, these
strategies work in a complementary fashion in criminal forensic
settings, likely because criminal forensic clients tend to be less
sophisticated regarding the symptoms they report, as previously
discussed (Wygant et al., 2007).
Although F-r performed quite well in this study, it is important
to note a significant caution against solely relying on the quasi-rare
symptom detection strategy. Rogers (2008; Rogers et al., 2003)
noted that because these symptoms are not necessarily rare in
clinical populations, items that are infrequent in normative (rather
than clinical) populations may have different endorsement fre-
quency in various clinical groups. This is exemplified by the
original F scale, which demonstrated widely varying mean scores
in different diagnostic groups (e.g., Rogers et al., 2003). This has
significant implication for, among other things, determining opti-
mal cut scores, which have indeed varied greatly for the original F
scale (Rogers et al., 2003). However, as indicated earlier, F-r is
different from the original F scale in an important way, as it is
composed of infrequent items in the current MMPI–2 normative
sample, whereas many items on the original F scales were no
longer infrequently endorsed in the restandardization sample (Tel-
legen & Ben-Porath, 2008). Nonetheless, it is imperative that
future research continue to examine F-r in various diagnostic
groups to determine whether the same variations in mean scores
persist. Such research would also have significant implications on
deriving stable cut scores to classify malingering, which are dis-
cussed next.
Another important goal of this investigation was to determine
optimal cut scores on the MMPI–2-RF validity scales to classify
malingering versus nonmalingering defendants. We focused on F-r
and FP-r because these scales were associated with the greatest
differentiation in this sample as well as being designed to measure
overreporting of psychopathology. When determining optimal cut
scores, it is important to consider whether the measures should be
used to screen in or screen out malingering. The former would
emphasize sensitivity and reducing false-negative prediction errors
(i.e., 1  NPP), but often at a cost of an increased false-positive
error rate. Conversely, when the goal is to screen out malingerers,
cut scores should emphasize high specificity and low false-positive
prediction errors (i.e., 1  PPP), at the cost of increased nonde-
tection of malingering. Although our goal in recommending cut
scores would be to minimize false-positive errors, as we would
prefer to avoid designating test takers as malingerers unless sub-
stantial evidence for such responding is present, the present data
can speak to the scales’ utility in both scenarios.
Figure 2. A: Receiver operating characteristic (ROC) curves for differ-
entiating between malingering and nonmalingering (including intermedi-
ates) groups. B: ROC curves for differentiating between malingering and
nonmalingering (excluding intermediates) groups. Diagonal segment is
indicative of chance prediction. F-r  Infrequent Responses; FP-r 
Infrequent Psychopathology Responses.
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The current findings clearly show that the optimal cut score for
F-r is 120T in this sample, which is in accordance with the
recommended cut score outlined in the MMPI–2-RF manual (Ben-
Porath & Tellegen, 2008); however, it is important to keep in mind
that even at a high correct classification rate of nonmalingering
(88%–91%), when base rates are very low, more than one third of
positive predictions will be errors. Thus, clinicians should be
careful using F-r as a screening-in tool in low base-rate settings.
On the other hand, a cut score of 100T was associated with almost
perfect sensitivity, that is, almost all malingerers will score at least
100T on F-r. Thus, this scale could serve as an excellent screening
measure of malingering, but clinicians should be aware that this
scale has the potential to yield a high number of false-positive
errors, especially at these lower cut scores.
The optimal cut score for FP-r in this investigation is 110T,
which is slightly higher than the manual’s recommendation (100T;
see Ben-Porath & Tellegen, 2008). FP-r was generally associated
with less sensitivity than F-r but with higher rates of specificity,
indicating that this scale will yield fewer false-positive classifica-
tions but also miss more individuals who malinger. Of course, it is
important to note that even with high levels of specificity (97%
when intermediate participants are removed), PPP values are low
at the 15% base rate (.78) by any convention suggested earlier (i.e.,
.80 or .90), thus further emphasizing the difficulty of using these
scales to rule in malingering.
It is important, however, to consider that clinicians would not
use these scales in isolation when making decisions about malin-
gering versus nonmalingering. Any test score warrants corrobora-
tion by extratest information. As such, although F-r scores of 120T
and/or FP-r scores of 110T might indicate a substantial likelihood
for malingering, other information (e.g., presence of external in-
centive, no previous mental health treatment history, other test
scores) would be needed before malingering could be ruled in. In
this light, the classification accuracies of F-r and FP-r are impres-
sive.
A final point of discussion is of methodological nature. In the
current study, we used a known-groups design with a well-
established external measure (SIRS) as the criterion on which
groups were formed. Although the SIRS has excellent specificity
and PPP rates, sensitivity rates are lower (Rogers et al., 1992).
Several malingering individuals would have been classified as
indeterminate by the SIRS and included among nonmalingerers in
the current study; therefore, their presence in the nonmalingering
group might violate the assumption of a bona fide known-groups
design. Consequently, we also analyzed the data without the par-
ticipants who were classified as indeterminate. The same pattern of
findings emerged (albeit somewhat stronger), and it is noteworthy
that classification accuracies, especially at low base rates, im-
proved substantially. Future researchers should take these findings
into account and weigh the importance of generalizability of
findings from a sample to a population that obviously includes
intermediates versus need for clean groups with the potential
overstatement of scales’ utility in detecting malingering.
There are some limitations of this research that need to be
acknowledged. First, it is important to note that although the SIRS
is currently considered the gold standard for assessing malinger-
ing, this external criterion method is not perfect, and it too is
associated with some classification error. Although using a cut
score of three or more primary scales in the probable feigning or
one scale in the definite feigning range is associated with near-
perfect specificity, sensitivity has varied in different investigations
(Gothard, Viglione, Meloy, & Sherman, 1995; Rogers et al., 1992).
This would suggest that our current findings may be an underes-
timate in detecting malingering, as some actual malingerers may
have been in the nonmalingering group. These findings therefore
require replication using other research designs (e.g., analogue
simulation designs) and other response bias criterion measures.
Moreover, because of the archival nature of the database, we
could not calculate reliability estimates for the SIRS, including
internal consistency and interrater reliability. However, as indi-
cated earlier, previous research has consistently reported very high
reliability estimates, and given the structured response format,
these estimates are not surprising, and it is unlikely that significant
random measurement error has influenced our results.
Table 3
Classification Accuracy Statistics for F-R and FP-R in Differentiating Between Malingering and Nonmalingering Groups
Cutoff score SN SP OCCa
BR  .15 BR  .30 BR  .50
PPP NPP PPP NPP PPP NPP
F-r
T  120 .89 .88/.91 .88/.91 .56/.64 .98/.98 .76/.81 .95/.95 .88/.91 .89/.89
T  115 .93 .82/.84 .84/.86 .47/.51 .98/.98 .68/.72 .96/.96 .83/.86 .92/.92
T  105 .96 .78/.80 .82/.84 .43/.46 .99/.99 .65/.67 .98/.98 .81/.83 .95/.96
T  100 .96 .72/.74 .78/.79 .38/.40 .99/.99 .60/.62 .98/.98 .78/.79 .95/.95
FP-r
T > 110 .67 .94/.97 .88/.90 .66/.78 .94/.94 .82/.90 .87/.87 .92/.95 .74/.74
T  100 .74 .90/.92 .86/.88 .56/.63 .95/.95 .76/.80 .89/.89 .88/.90 .78/.78
T  90 .74 .85/.88 .81/.85 .46/.52 .95/.95 .67/.72 .88/.89 .83/.86 .77/.77
T  80 .85 .78/.81 .79/.82 .40/.44 .97/.97 .62/.66 .92/.93 .79/.82 .84/.85
Note. Optimal cut score is set in bold font. Values to the left of a slash are when the nonmalingering group with intermediates is used, whereas values
to the right of a slash are when the nonmalingering group without intermediates is used. F-r  Infrequent Responses; FP-r  Infrequent Psychopathology
Responses; SN  sensitivity; SP  specificity; OCC  overall correct classification; BR  base rate; PPP  positive predictive power; NPP  negative
predictive power; T  T score.
a OCC values are based on base rates in the current sample (.22 and .23 for nonmalingering groups with and without intermediates, respectively).
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In light of these limitations, we also have recommendations for
future research. The results of the current investigation warrant
replication in samples derived from different contexts (correc-
tional, inpatient, personal injury, etc.). Researchers also need to
continue to use other research designs, including analogue simu-
lation and bootstrapping paradigms (see Rogers, 2008). It is also
important to examine the utility of these scales in identifying
malingering of specific forms of psychopathology with specific
diagnostic comparison groups. Such research has particular impli-
cations for determining which validity scale works best in different
contexts but also for determining the stability of optimal cut
scores, particularly with F-r. Finally, the MMPI–2-RF primarily
makes use of the rare symptom and quasi-rare symptom detection
strategies (cf. Rogers, 2008),5 which have proved quite successful.
Nonetheless, Rogers et al. (2003) showed that the erroneous sub-
type detection strategy (as approximated with the MMPI–2 Dis-
simulation scale) is a close second. Therefore, it would be worth-
while to explore whether additional malingering detection
strategies would add useful information to the rare symptom
strategy in identifying such response bias.
5 It is unclear to what symptom strategy FBS-r adheres, as it is a derivate
of the MMPI–2 FBS, which was developed by examining items that
differentiated between malingering and nonmalingering groups in a foren-
sic neuropsychology sample. R. Rogers (personal communication, June
2009) suggested that the FBS adheres to a mixed strategy that is not clearly
defined.
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